Powder for solution for injections of Amoksil-K is shown for treatment of the bacterial infections caused by microorganisms, sensitive to Amoksilu-K, such as:

• heavy infections of a throat, nose and ear (a mastoiditis, peritonsillar infections, an epiglottiditis and sinusitis with the accompanying heavy system signs and symptoms);
• exacerbation of chronic bronchitis (after confirmation of the diagnosis);
• extra hospital pneumonia;
• cystitis;
• pyelonephritis;
• an infection of skin and soft tissues, including bacterial cellulitises, stings of animals, heavy dentoalveolyarny abscesses with widespread cellulitis;
• an infection of bones and joints, including osteomyelitis;
• intra belly infections;
• an infection of genitals at women.

Prevention of bacterial infections at extensive surgeries in the following zones:

• digestive tract;
• bodies of a small pelvis;
• head and neck;
• bilious ways.

Structure

Active ingredients: amoxicillin, clavulanic acid;

1 bottle the Hypersensitivity to active ingredients, penicillin and to other components of medicament contains sterile mix (5:1) amoxicillin of sodium salt and clavulanate of potassium salt in recalculation on amoxicillin of 1.0 g and clavulanic acid of 0.2 g

Contraindication

.

Heavy allergic reaction of immediate type (for example an anaphylaxis) on another beta laktamny an antibiotic (cephalosporin, karbapeny or to monobakta) in the anamnesis.

Jaundice/abnormal liver function in the anamnesis which was caused by amoxicillin/clavulanic acid.

Route of administration

Dose is given as the content of amoxicillin/clavulanic acid if the dose of a separate component is not specified.

When choosing a dose of Amoksila-K for treatment defined infections needs to be considered:

• expected activators and their expected sensitivity to antibacterial substances;
• weight and localization of an infection;
• age, body weight and a condition of function of kidneys of the patient as it is described further.

can apply This dosage form of Amoksila-K in a daily dose to 3000 mg of amoxicillin and 600 mg of clavulanic acid. In case of need uses of a high dose of amoxicillin it is necessary to appoint other Amoksila-K form in order to avoid ultrahigh day doses of clavulanic acid.

Duration of treatment is defined by the doctor individually. Some infections (for example osteomyelitis) demand long-term treatment. Duration of treatment should not exceed 14 days without assessment of results of use and a clinical picture.

Feature of use

Pregnant

Should avoid use of medicament during pregnancy, except for cases when the expected advantage for mother exceeds potential risk for a fruit.

to Apply

to children from the first days of life.

Drivers

Researches on studying ability to influence speed of response at control of motor transport or work with other mechanisms. However emergence of such side reactions as allergic reactions, dizziness, spasms can affect ability to run motor transport or to work with other mechanisms.

Overdose

Overdose can be followed by symptoms from digestive tract and disturbances of water and electrolytic balance. The specified symptoms treat symptomatic, with special attention to correction of water and electrolytic balance.

that can sometimes lead to a renal failure. There are messages about amoxicillin precipitation in an uric catheter at use of intravenous Amoksila-K in high doses. It is necessary to check passability of a catheter regularly.

Amoksil-K from a blood-groove with a hemodialysis method.

Side effects

• Infection and invasion. Often – candidiasis of skin and mucous membranes.
• from blood and lymphatic systems. Seldom – a reversible leukopenia (including a neutropenia) and thrombocytopenia.
• from the immune system. Frequency is unknown – a Quincke's disease; anaphylaxis; syndrome similar to a serum disease; allergic vasculitis.
• from nervous system. Infrequently – dizziness, a headache.
• from vessels. Seldom – thrombophlebitis in the injection site of medicine.
• from digestive tract. Often – diarrhea. Infrequently – nausea, vomiting, digestion violation.
• from a gepatobiliarny system. Infrequently – moderate increase in level of nuclear heating plant and/or ALT is observed at the patients receiving beta laktamnye antibiotics.
• from skin and hypodermic fabric. Infrequently – skin rash, an itch, a small tortoiseshell. Seldom – a polymorphic erythema.

Interaction

At the same time is not recommended to be applied probenetsid. Probenetsid reduces canalicular secretion of amoxicillin. Simultaneous application of Amoksila-K can lead to increase in level in amoxicillin blood for a long time, but not clavulanic acid.

Simultaneous use of Allopyrinolum during treatment by amoxicillin increases the probability of allergic skin reactions. There are no data on simultaneous application of Amoksila-K and Allopyrinolum.

As well as other antibiotics, Amoksil-K can influence intestines flora that leads to reduction of a reabsorption of estrogen and decrease in efficiency of the combined oral contraceptives.

to Store

in original packing at a temperature not above 25 °C.

to Store

out of children's reach.

Expiration date - 2 years.